Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
H&Q Healthcare Investors
investment firm
About
H&Q Healthcare Investors provides early and later stage funding and is a Massachusetts-based healthcare fund.
Highlights
Details
- Operating Status
- Active
- Investor Type
- Venture Capital
Investments
Number of Investments
Number of Lead Investments
10
1
H&Q Healthcare Investors has made 10 investments. Their most recent investment was on
Apr 3, 2014, when Neurovance raised $6.30M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Apr 3, 2014
Neurovance
|
Series A | $6.30M | Biotechnology | — |
|
Mar 1, 2013
CardioKinetix
|
Series E | $23M | Biotechnology | — |
|
Jan 8, 2013
Labcyte
|
Series D | $5.30M | Alternative Medicine | — |
|
Oct 18, 2012
Neurovance
|
Series Unknown | $7M | Biotechnology | — |
|
Oct 5, 2011
Puma Biotechnology
|
Post-IPO Equity | $55M | Biotechnology | — |
Exits
H&Q Healthcare Investors has had 6 exits. H&Q Healthcare Investors most notable exits include Labcyte , Neurovance
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Jan 30, 2019 | Labcyte | M&A | Alternative Medicine | Detail |
| Mar 2, 2017 | Neurovance | M&A | Biotechnology | Detail |
| May 11, 2015 | PHT Corporation | M&A | Clinical Trials | Detail |
| Apr 20, 2012 | Puma Biotechnology | IPO | Biotechnology | Detail |
| Mar 19, 2008 | CardioNet | IPO | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
